Monday, September 22, 2025

11:00 AM - 12:30 PM

Grand Copthorne Waterfront Hotel - Waterfront Ballroom I

---

Details

To date, targeted genotyping strategies remain the cornerstone of clinical pharmacogenetics. However, next-generation sequencing technologies (NGS) have developed rapidly and are becoming increasingly attractive as an alternative strategy. The application of advanced sequencing technologies can overcome the problems associated with rarer and more population-specific variants than commonly used targeted pharmacogenetic panels. On the other hand, technical feasibility and challenges related to cost and data management may limit the transferability of these approaches into clinical practice. In this symposium challenges will be outlined and solutions presented and discussed in the context of implementation examples from clinical practice showcasing research and implementation from the Asia-Pacific region.